cPLA2 is phosphorylated and activated by MAP kinase

LL Lin, M Wartmann, AY Lin, JL Knopf, A Seth… - Cell, 1993 - cell.com
LL Lin, M Wartmann, AY Lin, JL Knopf, A Seth, RJ Davis
Cell, 1993cell.com
Treatment of cells with agents that stimulate the release of arachldonic acid causes
increased serine phosphorylation and activation of cytosolic phospholipase A2 (cPLA*).
Here we report that cPLAz is a substrate for mitogen-activated protein (MAP) kinase.
Moreover, phosphorylation by MAP kinase increases the enzymatic activity of cPLA2. The
site of cPLAz phosphorylatlon by MAP kinase, Ser-505, is identical to the major site of cPLA2
phosphorylation observed in phorbol ester-treated cells. Replacement of Ser-505 with Ala …
Summary
Treatment of cells with agents that stimulate the release of arachldonic acid causes increased serine phosphorylation and activation of cytosolic phospholipase A2 (cPLA*). Here we report that cPLAz is a substrate for mitogen-activated protein (MAP) kinase. Moreover, phosphorylation by MAP kinase increases the enzymatic activity of cPLA2. The site of cPLAz phosphorylatlon by MAP kinase, Ser-505, is identical to the major site of cPLA2 phosphorylation observed in phorbol ester-treated cells. Replacement of Ser-505 with Ala resulted in a mutant cPLA2 that is not a substrate for MAP kinase and causes little or no enhanced agonist-stimulated arachidonate release from intact cells. Taken together, these data indicate that MAP kinase mediates, at least in part, the agonist-induced activation of cPLA2.
cell.com